WallStreetZenWallStreetZen

NASDAQ: ETNB
89bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ETNB

Based on 4 analysts offering 12 month price targets for 89bio Inc.
Min Forecast
$14.00+57.66%
Avg Forecast
$27.75+212.5%
Max Forecast
$37.00+316.67%

Should I buy or sell ETNB stock?

Based on 4 analysts offering ratings for 89bio Inc.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ETNB stock forecasts and price targets.

ETNB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-07
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is ETNB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is ETNB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ETNB revenue forecast

What is ETNB's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$30.7M
Avg 2 year Forecast
$199.4M
Avg 3 year Forecast
$602.1M

ETNB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ETNB$8.88$27.75+212.50%Buy
KYTX$19.01$39.50+107.79%Strong Buy
SPRY$8.44$18.50+119.19%Buy
RLAY$6.11$23.50+284.62%Strong Buy
IMTX$10.26N/AN/A
View Top Biotech Stocks

89bio Stock Forecast FAQ

Is 89bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ETNB) stock is to Buy ETNB stock.

Out of 4 analysts, 1 (25%) are recommending ETNB as a Strong Buy, 2 (50%) are recommending ETNB as a Buy, 1 (25%) are recommending ETNB as a Hold, 0 (0%) are recommending ETNB as a Sell, and 0 (0%) are recommending ETNB as a Strong Sell.

If you're new to stock investing, here's how to buy 89bio stock.

What is ETNB's revenue growth forecast for 2026-2028?

(NASDAQ: ETNB) 89bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

89bio's revenue in 2024 is $0.On average, 4 Wall Street analysts forecast ETNB's revenue for 2026 to be $2,872,637,675, with the lowest ETNB revenue forecast at $707,804,160, and the highest ETNB revenue forecast at $4,470,479,853. On average, 3 Wall Street analysts forecast ETNB's revenue for 2027 to be $18,641,336,238, with the lowest ETNB revenue forecast at $5,880,291,097, and the highest ETNB revenue forecast at $37,335,033,153.

In 2028, ETNB is forecast to generate $56,297,639,548 in revenue, with the lowest revenue forecast at $18,314,082,003 and the highest revenue forecast at $95,380,584,321.

What is ETNB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ETNB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ETNB's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ETNB price target, the average ETNB price target is $27.75, with the highest ETNB stock price forecast at $37.00 and the lowest ETNB stock price forecast at $14.00.

On average, Wall Street analysts predict that 89bio's share price could reach $27.75 by Apr 5, 2025. The average 89bio stock price prediction forecasts a potential upside of 212.5% from the current ETNB share price of $8.88.

What is ETNB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ETNB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.